1. Главная
  2. Ресурсы
  3. Библиотечный поиск
Prognostic andclinicopathologicalsignificance ofDEPTOR expression incancer patients: ameta-analysis Binwu HuDeyao ShiXiao Lv2018 год

Prognostic and clinicopathological significance of DEPTOR expression in cancer patients: a meta-analysis
статья из журнала

Полный текстСтраница публикацииПубликация в OpenAlex
Аннотация: DEP domain containing mammalian target of rapamycin (mTOR)-interacting protein (DEPTOR), a recently discovered endogenous inhibitor of mTOR, has been found to be abnormally expressed in various tumors. Recent studies have demonstrated that DEPTOR could serve as a potential prognostic biomarker in several kinds of cancer. However, the prognostic value of DEPTOR is still controversial so far.PubMed, Embase and Web of Science were systematically searched to obtain all relevant articles about the prognostic value of DEPTOR in cancer patients. ORs or HRs with corresponding 95% CIs were pooled to estimate the association between DEP-TOR expression and the clinicopathological characteristics or survival of cancer patients.A total of nine eligible studies with 974 cancer patients were included in our meta-analysis. Our results demonstrated that the expression of DEPTOR was not associated with the overall survival (OS) (pooled HR=0.795, 95% CI=0.252-2.509) and event-free survival (EFS) (pooled HR=1.244, 95% CI=0.543-2.848) in cancer patients. Furthermore, subgroup analysis divided by sample size, type of cancer, Newcastle-Ottawa Scale (NOS) score and evaluation of DEPTOR expression showed identical prognostic value. In addition, our analysis also revealed that there was no significant association between expression level of DEPTOR and clinicopathological characteristics, such as tumor stage, lymph node metastasis, differentiation grade and gender.Our meta-analysis suggested that despite the fact that DEPTOR could be overexpressed or downregulated in cancer patients, it might not be a potential marker to predict the prognosis of cancer patients.
Год издания: 2018
Авторы: Binwu Hu, Deyao Shi, Xiao Lv, Fashuai Wu, Songfeng Chen, Zengwu Shao
Издательство: Dove Medical Press
Источник: OncoTargets and Therapy
Ключевые слова: PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology
Другие ссылки: OncoTargets and Therapy (PDF)
OncoTargets and Therapy (HTML)
DOAJ (DOAJ: Directory of Open Access Journals) (HTML)
Europe PMC (PubMed Central) (PDF)
Europe PMC (PubMed Central) (HTML)
PubMed Central (HTML)
PubMed (HTML)